openPR Logo
Press release

1000th child to be supported with the Berlin Heart ventricular assist device

01-26-2012 03:10 AM CET | Health & Medicine

Press release from: Berlin Heart

15-year-old Ivan watching a football game at the Tivoli Stadium in Innsbruck.

15-year-old Ivan watching a football game at the Tivoli Stadium in Innsbruck.

Berlin, 24th January 2012:

The EXCOR® Pediatric ventricular assist device has been implanted in more than 1000 cases.
This so-called artificial heart enables seriously ill children with heart defects to bridge the time until a suitable donor heart is found. It is the only system worldwide that is designed especially for the physiological needs of children.

This system was invented in Berlin and is used in children of all ages all over the world. The youngest patient that was supported with this device was just over two days old. EXCOR® Pediatric has just been approved in the USA by the FDA (Food and Drug Administration).

End of 2011, a 15-year-old boy from Tyrol who was suffering from myocarditis was implanted with the device being the 1000th EXCOR® patient at the University hospital in Innsbruck. In the meantime, he has already been successfully transplanted and will be able to go home within the next few days. Only with the help of the EXCOR® system, that supported his heart for 53 days he was able to survive the wait for a donor heart.

The clinic in Innsbruck is extremely well experienced with the handling of the ventricular assist device made by Berlin Heart, which was first implanted there in a child in Austria in 2000. With the implantation performed by Dr. David Vondrys and Prof. Herwig Antretter, Ivan was even able to visit a soccer game at the Tivoli Stadium in Innsbruck, accompanied by his clinical team. As a great soccer fan that was a very special event for him “We are constantly trying to make our little patients happy with such experiences which bring a small change to their clinic routine. A little while ago, we visited Innsbruck airport and a fire station with another patient and the little boy was even
able to ride the fire ladder“ says Dr. Ulrich Schweigmann, the
responsible pediatric cardiologist.

„We are excited to see that the 1000th patient is feeling so well and was able to make such an excursion. We are focussing on the development of a new mobile driving unit, that will allow children to move around even more freely” says Dr. Stefan Thamasett, General Manager of the Berlin Heart GmbH.

About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable
and external ventricular assist devices for patients of every age and body size. The devices INCOR®, EXCOR® Adult and EXCOR® Pediatric can support failing hearts short-, mid- and long-term and therefore offer a life-saving therapy. Customers moreover benefit from clinical and technical support by Berlin Heart VAD specialists who are available 7-24. INCOR® and EXCOR® Adult are not FDA-approved, but widely used in Europe. The company is the market leader in Germany and Europe.
About EXCOR®
EXCOR® is a para-corporeal ventricular assist device for patients of all age groups, from newborns to adults. It is used for short-, mid- and long-term cardiac support and can support failing hearts for any duration from a couple of days to several months and years. Since the first implantation in 1988 EXCOR® has been implanted in more than 3.000 patients worldwide.

The Berlin Heart EXCOR® Pediatric Ventricular Assist Device (EXCOR® Pediatric) is approved for use by the FDA under a Humanitarian Device Exemption. All other products are not available in the US.

Berlin Heart GmbH
Katharina Schubert
Marketing & PR
Wiesenweg 10
12247 Berlin
schubert@berlinheart.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 1000th child to be supported with the Berlin Heart ventricular assist device here

News-ID: 208178 • Views: 4004

More Releases from Berlin Heart

The 1,500th child supported by the Berlin Heart ventricular assist device has be …
The EXCOR® Pediatric ventricular assist device (VAD) has been implanted in more than 1,500 children worldwide to save their lives. In June 2014 for the 1,500th time, the EXCOR® Pediatric device was implanted to save the life of a child: a 14-year-old boy from Hong Kong who was suffering from dilated cardiomyopathy since the age of four was supported with the life-saving device. Up to that point the teenager had
100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed. The clinics in Spain benefit from an excellent service by Palex Medical
Regensburg patient for five years on a ventricular assist device
It was a special anniversary for Mr. Max. K from the Bavarian town Ortenburg: For five years now he is kept alive by the ventricular assist device (VAD) INCOR®. Within the University Hospital Regensburg Mr. K is the patient with the longest support time by this device. The patient’s story of the 54-year-old patient goes back a few years. After he had a strong flu in 2006, Max K.’s right heart
Berlin Heart employees cook for families at the Ronald McDonald house
In the afternoon of July, 31st 2014 ten Berlin Heart employees gathered at the Ronald McDonald House in Berlin-Wedding to prepare a three-course-menu for the residents. That night mache with chanterelle and caramelized walnuts followed by coq au vin and a peach and raspberry crumble with pistachios and vanilla ice cream as desert were on the menu. The aim of the volunteers was not only to serve a delicious dinner

All 5 Releases


More Releases for EXCOR®

100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed. The clinics in Spain benefit from an excellent service by Palex Medical
1. Japanese EXCOR® Pediatric patient successfully transplanted
Berlin, 19.06.2013: The wait for a donor heart is over for the 1st Japanese patient treated with the EXCOR® Pediatric. On May 20th, 2013 the two-year-old girl was successfully transplanted at Morgan Stanley Childrens Hospital, New York Columbia Presbyterian Medical Center. According to the patient’s physicians, she tolerated the procedure well and is recovering as expected. In August 2012, for the first time in Japan’s history, it was possible
Longest support time with the EXCOR® Pediatric ventricular assist device
Six year old Lara from Erlangen is the toddler with the longest support time of a ventricular assist device (VAD) in the world. The small patient was treated an entire 877 days with the VAD EXCOR® Pediatric in the University Hospital in Erlangen and, thanks to this therapy, could recover so well that she was now able to receive a new heart a few days ago. In February 2010 Lara was in
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007, is the first prospective clinical
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
Berlin Germany 12 April 2011: The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled. The study, which enrolled the first patient in November 2007,
Successful transatlantic EXCOR® air ambulance transportations
Berlin, 30 March 2011. Four young children suffering from severe heart failure and consequently supported by the EXCOR® ventricular assist device, were safely and successfully transported by aircraft during the last months. The so-called artificial heart was implanted in order to assist the patient’s heart function of pumping blood through the body. As a life-saving device, it bridges the time until a donor heart is found and transplantation becomes possible.